DK3229827T3 - Modificerede peptider og anvendelse deraf til behandling af kroniske inflammatoriske sygdomme - Google Patents
Modificerede peptider og anvendelse deraf til behandling af kroniske inflammatoriske sygdomme Download PDFInfo
- Publication number
- DK3229827T3 DK3229827T3 DK15885769T DK15885769T DK3229827T3 DK 3229827 T3 DK3229827 T3 DK 3229827T3 DK 15885769 T DK15885769 T DK 15885769T DK 15885769 T DK15885769 T DK 15885769T DK 3229827 T3 DK3229827 T3 DK 3229827T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- application
- inflammatory diseases
- chronic inflammatory
- modified peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462091379P | 2014-12-12 | 2014-12-12 | |
| PCT/EP2015/079395 WO2016192819A2 (en) | 2014-12-12 | 2015-12-12 | Modified peptides and their use for treating chronic inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3229827T3 true DK3229827T3 (da) | 2019-12-09 |
Family
ID=56110117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15885769T DK3229827T3 (da) | 2014-12-12 | 2015-12-12 | Modificerede peptider og anvendelse deraf til behandling af kroniske inflammatoriske sygdomme |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10213482B2 (da) |
| EP (1) | EP3229827B1 (da) |
| JP (1) | JP6659693B2 (da) |
| CN (1) | CN107454846B (da) |
| CA (1) | CA2970203C (da) |
| DK (1) | DK3229827T3 (da) |
| ES (1) | ES2759749T3 (da) |
| WO (1) | WO2016192819A2 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018109285A1 (fr) * | 2016-12-13 | 2018-06-21 | Centre National De La Recherche Scientifique | Peptides pour le traitement du neurolupus |
| WO2019096018A1 (en) * | 2017-11-14 | 2019-05-23 | The Hong Kong University Of Science And Technology | Autophagy inhibitors |
| CN112055747A (zh) * | 2017-12-07 | 2020-12-08 | 巴尔工业株式会社 | 选定分子的导入方法以及含有抑制剂的组合物 |
| WO2021198135A1 (en) * | 2020-03-29 | 2021-10-07 | Immupharma France Sa | Method of treating viral infections |
| CN114381461B (zh) * | 2022-03-24 | 2022-07-19 | 中国人民解放军军事科学院军事医学研究院 | 一种通过清除野生型p53蛋白促进ATG5-ATG12共轭增强细胞自噬的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD205340A1 (de) | 1982-03-23 | 1983-12-28 | Adw Ddr | Verfahren zur herstellung von fett in wasser-emulsionen |
| DD204831A1 (de) | 1982-05-12 | 1983-12-14 | Gerd Wagner | Rollbodenbunker fuer hackfruchterntemaschinen |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4751181A (en) | 1984-12-31 | 1988-06-14 | Duke University | Methods and compositions useful in the diagnosis and treatment of autoimmune diseases |
| US5561222A (en) | 1989-11-15 | 1996-10-01 | Duke University | RNA-binding proteins useful for the control of cellular genetic processing and expression |
| WO1995025124A1 (en) | 1994-03-14 | 1995-09-21 | University Of Southern California | Methods to diagnose and treat hiv-1 infection |
| US5527688A (en) | 1994-04-08 | 1996-06-18 | Pierce Chemical Company | Rapid assays for protein kinase activity |
| US6696545B1 (en) | 1997-04-11 | 2004-02-24 | Sangstat Medical Corporation | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| WO2000020583A1 (en) | 1998-10-08 | 2000-04-13 | Zymogenetics, Inc. | Ribonucleoprotein homolog zrnp1, having also homology to the gnrh receptor |
| EP1425295B1 (en) | 2001-09-06 | 2009-12-23 | Centre National De La Recherche Scientifique (Cnrs) | Modified peptides and their use for the treatment of autoimmune diseases |
| FR2829768B1 (fr) | 2001-09-18 | 2003-12-12 | Centre Nat Rech Scient | Utilisation de peptides comportant des modifications de type post-traductionnel dans le cadre du traitement de pathologies auto-immunes |
| FR2900341B1 (fr) | 2006-04-27 | 2012-09-14 | Centre Nat Rech Scient | Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer |
| CN107011431B (zh) | 2007-01-30 | 2020-11-06 | 埃皮瓦克斯公司 | 调节性t细胞表位、组合物及其用途 |
| FR2931360B1 (fr) | 2008-05-20 | 2012-05-18 | Centre Nat Rech Scient | Nanoparticules contenant un peptide, vecteurs les contenant et utilisations pharmaceutiques desdits nanoparticules et vecteurs |
| WO2013088194A1 (en) | 2011-12-13 | 2013-06-20 | Centre National De La Recherche Scientifique | Modified peptides and their use for treating autoimmune diseases |
-
2015
- 2015-12-11 US US14/966,679 patent/US10213482B2/en active Active
- 2015-12-12 CN CN201580073837.1A patent/CN107454846B/zh active Active
- 2015-12-12 WO PCT/EP2015/079395 patent/WO2016192819A2/en active Application Filing
- 2015-12-12 JP JP2017530593A patent/JP6659693B2/ja active Active
- 2015-12-12 CA CA2970203A patent/CA2970203C/en active Active
- 2015-12-12 EP EP15885769.8A patent/EP3229827B1/en active Active
- 2015-12-12 ES ES15885769T patent/ES2759749T3/es active Active
- 2015-12-12 DK DK15885769T patent/DK3229827T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3229827A2 (en) | 2017-10-18 |
| CN107454846A (zh) | 2017-12-08 |
| CA2970203A1 (en) | 2016-12-08 |
| JP6659693B2 (ja) | 2020-03-04 |
| WO2016192819A3 (en) | 2017-02-09 |
| CA2970203C (en) | 2023-03-14 |
| EP3229827B1 (en) | 2019-09-04 |
| ES2759749T3 (es) | 2020-05-12 |
| US10213482B2 (en) | 2019-02-26 |
| WO2016192819A2 (en) | 2016-12-08 |
| JP2018502071A (ja) | 2018-01-25 |
| US20160166636A1 (en) | 2016-06-16 |
| CN107454846B (zh) | 2021-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3283106T3 (da) | Terapeutiske antistoffer og anvendelser deraf | |
| DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
| DK3331915T3 (da) | Immun-checkpoint-inhibitorer til anvendelse til behandling af blodbårne cancere | |
| DK3280441T3 (da) | Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3259597T3 (da) | Pvrig-polypeptider og fremgangsmåder til behandling | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3653221T3 (da) | Anti-pvrig-antistoffer og anvendelsesfremgangsmåder | |
| DK3215532T3 (da) | Anti-TIM3-antistoffer og fremgangsmåder til anvendelse | |
| DK3119797T3 (da) | Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose | |
| DK3148579T3 (da) | Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3333191T3 (da) | Anti-C10ORF54-antistoffer og anvendelser deraf | |
| DK3126388T3 (da) | Anti-EGFRvIII-antistoffer og anvendelser deraf | |
| DK3096798T3 (da) | Plasmakallikreinbindende proteiner og anvendelser deraf til behandling af hereditært angioødem | |
| DK3227675T3 (da) | Activin-actrii-antagonister og anvendelser til behandling af myelodysplastisk syndrom | |
| KR102068915B9 (ko) | 조직 인자 경로 억제제 항체 및 그의 용도 | |
| DK3201336T3 (da) | Fremgangsmåder til ekstrahering og oprensning af ikke-denaturerede proteiner | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3197472T3 (da) | Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3498292T3 (da) | Uspa2-proteinkonstruktioner og anvendelser deraf | |
| DK3394065T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf | |
| DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
| DK3242947T3 (da) | Genterapi og elektroporese til behandling af maligniteter |